{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T23:21:44Z","timestamp":1770938504408,"version":"3.50.1"},"reference-count":143,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Medicine"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.3109\/07853890109002081","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T08:24:53Z","timestamp":1208334293000},"page":"291-304","source":"Crossref","is-referenced-by-count":22,"title":["Oncolytic viruses as therapeutic agents"],"prefix":"10.1080","volume":"33","author":[{"given":"Oliver","family":"Wildner","sequence":"first","affiliation":[{"name":"Charit\u00e9 - Campus Berlin-Buch (Robert-Rossle-Klinik), Humboldt-Universitat zu Berlin, Labor fur Gentherapie, 13122, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"82","article-title":"Sulla scomparsa di un enorme cancro vegetante del callo dell'utero senza cura chirurgica","volume":"9","author":"De Page N G","year":"1912","unstructured":"De Page N G. Sulla scomparsa di un enorme cancro vegetante del callo dell'utero senza cura chirurgica. Ginecologia 1912; 9: 82\u20138","journal-title":"Ginecologia"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)91790-3"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195611\/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)92232-X"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.4.836"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4804(92)90310-V"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196507)18:7<863::AID-CNCR2820180714>3.0.CO;2-V"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/80.16.1305"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830901)52:5<856::AID-CNCR2820520519>3.0.CO;2-4"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195209)5:5<1025::AID-CNCR2820050518>3.0.CO;2-Q"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.12.4736"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199304000-00016"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1851332"},{"key":"e_1_2_1_16_1","first-page":"724","article-title":"West Nile, Ilh\u00e9us and Bunyamwera virus infection in man","volume":"31","author":"Southam C M","year":"1951","unstructured":"Southam C M, Moore A E. West Nile, Ilh\u00e9us and Bunyamwera virus infection in man. J. Trop Med 1951; 31: 724\u201341","journal-title":"J. Trop Med"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5286.373"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.9-1323"},{"key":"e_1_2_1_19_1","first-page":"410","article-title":"Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of HSV-tk","volume":"59","author":"Wildner O","year":"1999","unstructured":"Wildner O, Blaese R M, Morris J C. Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of HSV-tk. Cancer Res 1999; 59: 410\u20133","journal-title":"Cancer Res"},{"key":"e_1_2_1_20_1","first-page":"3411","article-title":"Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas","volume":"59","author":"Shinoura N","year":"1999","unstructured":"Shinoura N, Yoshida Y, Tsunoda R, Ohashi M, Zhang W, Asai A, et al. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas. Cancer Res 1999; 59: 3411\u20136","journal-title":"Cancer Res"},{"key":"e_1_2_1_21_1","first-page":"4167","article-title":"The role of the E1B 55 kDa gene in oncolytic adenoviral vectors expressing HSV-tk: assessment of anti-tumor efficacy and toxicity","volume":"60","author":"Wildner O","year":"2000","unstructured":"Wildner O, Morris J C. The role of the E1B 55 kDa gene in oncolytic adenoviral vectors expressing HSV-tk: assessment of anti-tumor efficacy and toxicity. Cancer Res 2000; 60: 4167\u201374","journal-title":"Cancer Res"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203251"},{"key":"e_1_2_1_23_1","first-page":"2559","article-title":"Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells","volume":"57","author":"Rodriguez R","year":"1997","unstructured":"Rodriguez R, Schuur E R, Lim H Y, Henderson G A, Simons J W, Henderson D R. Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells. Cancer Res 1997; 57: 2559\u201363","journal-title":"Cancer Res"},{"key":"e_1_2_1_24_1","first-page":"4200","article-title":"The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts","volume":"59","author":"Yu D C","year":"1999","unstructured":"Yu D C, Chen Y, Seng M, Dilley J, Henderson D R. The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts. Cancer Res 1999; 59: 4200\u20133","journal-title":"Cancer Res"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950017725"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430340050015851"},{"key":"e_1_2_1_27_1","first-page":"43","article-title":"Interleukin-6 modulated conditionally replicative adenovirus as an antitumor\/cytotoxic agent for cancer therapy","volume":"5","author":"Rancourt C","year":"1999","unstructured":"Rancourt C, Piche A, Gomez-Navarro J, Wang M, Alvarez R D, Siegal G P, et al. Interleukin-6 modulated conditionally replicative adenovirus as an antitumor\/cytotoxic agent for cancer therapy. Clin Cancer Res 1999; 5: 43\u201350","journal-title":"Clin Cancer Res"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.1.196-205.1988"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0493"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-938"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5392.1332"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(91)90024-T"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196507)18:7<863::AID-CNCR2820180714>3.0.CO;2-V"},{"key":"e_1_2_1_34_1","first-page":"619","article-title":"Attenuated veterinary virus vaccine for the treatment of cancer","volume":"17","author":"Csatary L K","year":"1993","unstructured":"Csatary L K, Eckhardt S, Bukosza I, Czegledi F, Fenyvesi C, Gergely P, et al. Attenuated veterinary virus vaccine for the treatment of cancer. Cancer Detect Prev 1993; 17: 619\u201327","journal-title":"Cancer Detect Prev"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9819"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.12.6803"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/77558"},{"key":"e_1_2_1_38_1","first-page":"2111","volume-title":"Fields' Virology","author":"Shenk T","year":"1996","unstructured":"Shenk T. Adenoviridea. Fields' Virology, B N Fields, D M Knipe, P M Howley. Lippincott-Raven, Philadelphia, PA 1996; 2111\u201348"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5304.1320"},{"key":"e_1_2_1_40_1","first-page":"1039","article-title":"Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation","volume":"7","author":"Tiainen M","year":"1996","unstructured":"Tiainen M, Pajalunga D, Ferrantelli F, Soddu S, Salvatori G, Sacchi A, et al. Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation. Cell Growth Differ 1996; 7: 1039\u201350","journal-title":"Cell Growth Differ"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/357082a0"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90147-J"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(87)90441-7"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-639"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/2057"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.12.9470-9478.1998"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.12.9479-9490.1998"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9293"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.3.2074-2083.1999"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.7.5333-5344.1999"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018652"},{"key":"e_1_2_1_52_1","first-page":"4369","article-title":"p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma","volume":"59","author":"Vollmer C M","year":"1999","unstructured":"Vollmer C M, Ribas A, Butterfield L H, Dissette V B, Andrews K J, Eilber F C, et al. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Res 1999; 59: 4369\u201374","journal-title":"Cancer Res"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.1999.0014"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-2254(200009\/10)2:5<353::AID-JGM130>3.0.CO;2-G"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.1.548-561.1997"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.50.1.202-212.1984"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90088-9"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.56.1.250-257.1985"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb08360.x"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.6.2.470-476.1986"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(77)90428-7"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(82)90381-6"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/78638"},{"key":"e_1_2_1_64_1","first-page":"2608","article-title":"Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice","volume":"59","author":"Gu D L","year":"1999","unstructured":"Gu D L, Gonzalez A M, Printz M A, Doukas J, Ying W, D'Andrea M, et al. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: evidence for reduced toxicity and enhanced antitumor activity in mice. Cancer Res 1999; 59: 2608\u201314","journal-title":"Cancer Res"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.11.1459"},{"key":"e_1_2_1_66_1","first-page":"5276","article-title":"Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy","volume":"46","author":"Moolten F L","year":"1986","unstructured":"Moolten F L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276\u201381","journal-title":"Cancer Res"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00008a014"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(96)00961-8"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1218(96)90049-X"},{"key":"e_1_2_1_70_1","first-page":"5274","article-title":"The \u201cbystander effect\u201d: tumor regression when a fraction of the tumor mass is genetically modified","volume":"53","author":"Freeman S M","year":"1993","unstructured":"Freeman S M, Abboud C N, Whartenby K A, Packman C H, Koeplin D S, Moolten F L, et al. The \u201cbystander effect\u201d: tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274\u201383","journal-title":"Cancer Res"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1317968"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300810"},{"key":"e_1_2_1_73_1","article-title":"Subcutaneous administration of a replication-competent adenovirus expressing HSV-tk to cotton rats: dissemination, persistence, shedding, and pathogenicity","author":"Wildner O","unstructured":"Wildner O, Morris J C. Subcutaneous administration of a replication-competent adenovirus expressing HSV-tk to cotton rats: dissemination, persistence, shedding, and pathogenicity. Hum Gene Ther, in press","journal-title":"Hum Gene Ther"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700001"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.21.11307"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2173860"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1086\/514600"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.16.1209"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.21.9829"},{"key":"e_1_2_1_80_1","first-page":"3963","article-title":"Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant","volume":"54","author":"Mineta T","year":"1994","unstructured":"Mineta T, Rabkin S D, Martuza R L. Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simplex viral mutant. Cancer Res 1994; 54: 3963\u20136","journal-title":"Cancer Res"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-938"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1994.5.2-183"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.8425"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-3-631"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-71-7-1597"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-8-2059"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-75-12-3679"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301184"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301205"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1997.8.5-533"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5357-1_59"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.1.119"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.15-2177"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950017211"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.11.1325"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700130"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900016"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12295238"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950016591"},{"key":"e_1_2_1_100_1","first-page":"222","article-title":"Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma","volume":"4","author":"Miyatake S","year":"1997","unstructured":"Miyatake S, Martuza R L, Rabkin S D. Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma. Cancer Gene Ther 1997; 4: 222\u20138","journal-title":"Cancer Gene Ther"},{"key":"e_1_2_1_101_1","first-page":"3861","article-title":"Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine\/rat cytochrome P450 2B1 and ganciclovirherpes simplex virus thymidine kinase gene therapies","volume":"59","author":"Aghi M","year":"1999","unstructured":"Aghi M, Chou T C, Suling K, Breakefield X O, Chiocca E A. Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine\/rat cytochrome P450 2B1 and ganciclovirherpes simplex virus thymidine kinase gene therapies. Cancer Res 1999; 59: 3861\u20135","journal-title":"Cancer Res"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.130.3386.1387"},{"key":"e_1_2_1_103_1","first-page":"1597","volume-title":"Fields' Virology","author":"Tyler K L","year":"1996","unstructured":"Tyler K L, Fields B N. Reoviruses and their replication. Fields' Virology, B N Fields, D M Knipe, P M Howley. Lippincott-Raven, Philadelphia, PA 1996; 1597\u2013623"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/128.6.811"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.28.2.444-449.1978"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01314776"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.12.3351"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.17.8135-8139.2000"},{"key":"e_1_2_1_109_1","first-page":"4682","article-title":"ras oncogenes in human cancer: a review","volume":"49","author":"Bos J L","year":"1989","unstructured":"Bos J L. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682\u20139, [published erratum appears in Cancer Res 1990 50 1352]","journal-title":"Cancer Res"},{"key":"e_1_2_1_110_1","first-page":"2173","volume-title":"Fields' Virology","author":"Berns K I","year":"1996","unstructured":"Berns K I. Parvoviridae: The viruses and their replication. Fields' Virology, B N Fields, D M Knipe, P M Howley. Lippincott-Raven, Philadelphia 1996; 2173\u201397"},{"key":"e_1_2_1_111_1","first-page":"3203","article-title":"Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells","volume":"49","author":"Dupressoir T","year":"1989","unstructured":"Dupressoir T, Vanacker J M, Cornelis J J, Duponchel N, Rommelaere J. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. Cancer Res 1989; 49: 3203\u20138","journal-title":"Cancer Res"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301161"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1990.tb07491.x"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.4.3018-3028.1998"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.11.8893-8903.1998"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(91)90024-T"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.9.5506-5515.1995"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.3.1331-1339.1996"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01741145"},{"key":"e_1_2_1_120_1","first-page":"677","article-title":"Immunization with virus-modified tumor cells","volume":"25","author":"Schirrmacher V","year":"1998","unstructured":"Schirrmacher V, Ahlert T, Probstle T, Steiner H H, Herold-Mende C, Gerhards R, et al. Immunization with virus-modified tumor cells. Semin Oncol 1998; 25: 677\u201396","journal-title":"Semin Oncol"},{"key":"e_1_2_1_121_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.6.2370"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.8.2636-2643.1988"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/334320a0"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.2.958-964.1999"},{"key":"e_1_2_1_125_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.21.11341"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-46817-4_34"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.6.2982"},{"key":"e_1_2_1_128_1","first-page":"4567","article-title":"Enhanced generation of cytotoxic T lymphocytes using recombinant vaccinia virus expressing human tumor-associated antigens and B7 costimulatory molecules","volume":"58","author":"Zajac P","year":"1998","unstructured":"Zajac P, Schutz A, Oertli D, Noppen C, Schaefer C, Heberer M, et al. Enhanced generation of cytotoxic T lymphocytes using recombinant vaccinia virus expressing human tumor-associated antigens and B7 costimulatory molecules. Cancer Res 1998; 58: 4567\u201371","journal-title":"Cancer Res"},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700066"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(90)90019-C"},{"key":"e_1_2_1_131_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-7032-1_4"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.4.933"},{"key":"e_1_2_1_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1992.9"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300508"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300643"},{"key":"e_1_2_1_136_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301003"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018832"},{"key":"e_1_2_1_138_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950016483"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.1.68-77.1996"},{"key":"e_1_2_1_140_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.1.21"},{"issue":"3","key":"e_1_2_1_141_1","first-page":"814s","article-title":"Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors","volume":"50","author":"Jain R K","year":"1990","unstructured":"Jain R K. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Res 1990; 50(3 Suppl)814s\u20139s","journal-title":"Cancer Res"},{"key":"e_1_2_1_142_1","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.1997.5089"},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700182"},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0598-444"}],"container-title":["Annals of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/07853890109002081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T22:28:54Z","timestamp":1770935334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/07853890109002081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":143,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.3109\/07853890109002081"],"URL":"https:\/\/doi.org\/10.3109\/07853890109002081","relation":{},"ISSN":["0785-3890","1365-2060"],"issn-type":[{"value":"0785-3890","type":"print"},{"value":"1365-2060","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}